Sestak I, Regan M, Dodson A, et al. Integration of clinical variables for the prediction of late distant recurrence in patients with oestrogen receptor positive breast cancer treated with 5 years of endocrine therapy. SABCS 2017, GS6-01.
Pembrolizumab als tweedelijnsbehandeling bij gevorderd urotheelcarcinoom
mrt 2017 | Uro-oncologie